Noumi Ltd
ASX:NOU
Noumi Ltd
noumi Ltd. engages in the manufacture and sale of food products. The firm is engaged in manufacturing dairy and plant-based beverages, nutritional products and ingredients used across the health and fitness industries. The firm's segments include Dairy and Nutritionals, and Plant-based Beverages. The Dairy and Nutritionals segment includes a range of dairy milk beverages, nutritional products, and performance and adult nutritional powders, including the Crankt brand. Its Plant-based Beverages segment includes a range of beverage products, such as liquid stocks, soy, rice, oat and almond beverages. The firm operates manufacturing facilities in Victoria and New South Wales (NSW) and produces key brands, including the MILKLAB range of shelf-stable dairy and plant-based milks, Australia’s Own, So Natural, Crankt, Vital Strength, VITALIFE and PUREnFERRIN lactoferrin.
noumi Ltd. engages in the manufacture and sale of food products. The firm is engaged in manufacturing dairy and plant-based beverages, nutritional products and ingredients used across the health and fitness industries. The firm's segments include Dairy and Nutritionals, and Plant-based Beverages. The Dairy and Nutritionals segment includes a range of dairy milk beverages, nutritional products, and performance and adult nutritional powders, including the Crankt brand. Its Plant-based Beverages segment includes a range of beverage products, such as liquid stocks, soy, rice, oat and almond beverages. The firm operates manufacturing facilities in Victoria and New South Wales (NSW) and produces key brands, including the MILKLAB range of shelf-stable dairy and plant-based milks, Australia’s Own, So Natural, Crankt, Vital Strength, VITALIFE and PUREnFERRIN lactoferrin.
EBITDA Surge: Full-year EBITDA reached $30.4 million, up 315% from FY '22, marking a fourfold improvement and reflecting strong operational progress.
Plant-Based Strength: Record performance in plant-based milks with EBITDA of $37.4 million and Milklab brand sales up over 10%, despite flat revenue due to discontinued licensed products.
Dairy Turnaround: Dairy and Nutritionals nearly broke even, a $20 million EBITDA turnaround from FY '22, with positive EBITDA in the second half.
Revenue Growth: Net revenue increased by $29 million to $551.6 million, showing the impact of improved product mix and operational focus.
Loss Narrows: Statutory loss improved by $114.2 million to a loss of $46.9 million, largely due to fewer impairments and absence of major litigation costs.
Cash & Debt: Cash increased by $2 million and conventional debt reduced by $2 million, despite legacy legal settlement payments.
Outlook Positive: Management expects ongoing strength in plant-based and continued margin and cost focus in dairy, with further Milklab brand investment planned.
